Coumarin: Chemical and pharmacological profile

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 6, 2012, Pages 236-240

  Jain, P K ^a   Joshi, Himanshu ^a  

^a Faculty of Pharmacy   (India)

Author keywords

Anti tumor activity; Baacteriostatic; Benzopyrone; Coumarin; Flavonoids

Indexed keywords

EID: 84876028091     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2012.2643     Document Type: Article

References (29)

1. Agarwal R. Synthesis & biological screening of some novel coumarin derivatives. Biochem Pharmacol. 2000; 6: 1042-1051.
2. Bruneton J. Immunotoxicity of epicutaneously applied anticoagulant rodenticide warfarin. Hampshire U K, Intercept Ltd.1999; 2: 245-263.
3. Bosland MC. Synthesis of vanillin ethers from bromomethylcoumarins as anti-inflammatory agents. San Diego Academic Press. 1991; 6: 162-177.
4. Constantinou AI., Kamath N., Hurley JS. A novel series of 5- (substituted)-aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines & pharmacological evaluation reported as a novel anti-inflammatory & analgesic effects. Eur. J. Can. 1998; 14: 19-27.
5. Cooke D., Fitzpatrick B., O'Kennedy R., McCormack T., Egan D. coumarin biochemical profile and recent developments. John Wiley & Sons. 1997; 3: 311-322.
6. Cooke D. recent advances on coumarin and its synthetic derivatives. Dublin City University, Dublin. 1999; 12: 125-139.
7. Chen H., Walsh CT. Synthesis of novel N-substituted-2-oxo-2H- 1-coumarin-3-carboxamide & evaluated for selective anti helicobacter pylori activity & cytotoxicity. Chem Biol. 2001; 8: 288-301.
8. Dexeus FH., Logothetis CJ., Sella A., Fitz K., Amato R., Reuben JM. Design & synthesis of some novel substituted coumarin & evaluated for anti-convulsant activity. J Clin Oncol. 1990; 8: 314-325.
9. Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., Thornes RD. novel coumarin derivatives containing 4,5-dihydro pyrazole moiety & reported molecular docking study & potential anti-tumour agents. Drug Metab Rev. 1990; 22: 490-503.
10. Egan D., O'Kennedy R. Synthesis of several novel coumarins derivatives with a 7-azomethine linkage and chromatographical analysis. J Chromatogr B. 1992; 5: 126-137.
11. Ebbinghaus SW., Mahler JL., Marshall ME. Novel Coumarin activity on albino rats and shows anti-coagulant and anti-oxidant activity. John Wiley & Sons. 1997; 45: 195-209.
12. Finn G., Kenealy E., Creaven B., Egan D. Coumarinyl aldehyde as a Michael acceptor type of calorimetric & fluorescent probe for cyanide in water. Cancer Letts. 2002; 18: 54-61.
13. Guilet D., Seraphin D., Rondeau D., Richomme P., Bruneton J. phytochemical profile of novel coumarin derivatives. Phytochemistry J. 2001; 58: 559-571.
14. Goodman & Gilman's. The Pharmacological basis of therapeutics: Blood coagulation and Anti-coagulant, thrombolytic and Anti-platelet drugs. 11th ed. (2006) 1325-1328.
15. Goodman & Gilman's, The Pharmacological basis of therapeutics: Analgesic-Antipyretics agents; Pharmacotherapy of gout. 11th ed. (2006) 1211-1218.
16. Keating G., O'Kennedy R. coumarin cytotoxicity activity on albino rats. John Wiley & Sons. 1997; 2: 54-66.
17. Kokron O., Maca S., Gasser G., Schmidt PR. Synthesis of novel coumarin 3-(N-aryl)-sulfonamides & evaluated for their anti-cancer activity and reported in vitro inhibitory activity on human platelet aggregation. Oncology. 1991; 48: 91-102.
18. Lake B. Synthesis & pharmacological investigation of 4- hydroxy coumarin derivatives & shown as anti-coagulant. Food Chem Tox. 1999; 3: 412-423.
19. Murray RDH., Mendez J., Brown SA. Coumarin activity in plants and bioorganism aspects. John Wiley. 1982; 2: 45-55.
20. Marshall ME., Butler K., Fried A. Screening of synthetic new hetrocyclic derivatives of 3-formyl-4-hydroxy coumarin and evaluated for Anti-Inflammatory activity in albino rats. Mol Biother. 1991; 3: 158-170.
21. Marshall ME., Butler K., Hermansen D. Structural modification of coumarin for increased Anti-Coagulation potency. Prostate. 1990; 17: 95-108.
22. Mahler JL., Gomella LG., Crawford ED., Glode LM., Zippe CD., Fair WR. Synthesis of novel coumarin bisindole derivatives & reported as anti-hyperlipidimic activity. Prostate. 1992; 20: 112-123.
23. Myers RB., Parker M., Grizzle WE. synthesis of stilbenecoumarin hybrid compounds & compounds has been reported as anticancer activity. J Cancer Res Clin Oncol. 1994; 12: 11-23.
24. Ojala T. PhD Thesis, University of Helsinki, Helsinki, Finland. 2001; 95-106.
25. Thornes RD., Lynch G., Sheehan MW. Relationship between structure and Anti-Coagulant activity of coumarin derivatives. Lancet. 1982; 2: 328-339.
26. Velasco-Velazquez MA., Agramonte-Hevia J., Barrera D., Jimenez-Orozco A., Garcia-Mondragon MJ., Mendoza-Patino N. Synthesis & biological evaluation of novel coumarin based inhibitors of CDC25 inhibitors. Cancer Letts. 2003; 19: 167-179.
27. Vuky J., Motzer RJ. Synthesis & pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonist & inverse agonist & reported 5-sub. 3-benzylcoumarin derivatives. Urol Oncol. 2000; 5: 240-249.
28. www.globalresearch.com-Desai UR. VCU School of Pharmacy, 2005.
29. www.golbalresearchonline.com-Friedli enterprises-Georges- Louis Friedli, 2001.